CD19 Is a Useful B Cell Marker After Treatment With...

CD19 Is a Useful B Cell Marker After Treatment With Rituximab: Comment on the Article by Jones et al

Kamburova, Elena G., Koenen, Hans J. M. P., Joosten, Irma, Hilbrands, Luuk B.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
65
Language:
english
Journal:
Arthritis & Rheumatism
DOI:
10.1002/art.37871
Date:
April, 2013
File:
PDF, 105 KB
english, 2013
Conversion to is in progress
Conversion to is failed